Cardiothoracic & vascular anesthesia

The effect of high-dose selenium on mortality and postoperative organ dysfunction in post-cardiotomy cardiogenic shock patients supported with mechanical circulatory support – A post-hoc analysis of the SUSTAIN CSX trial

J Crit CarePublished Secondary analysis of the SUSTAIN CSX randomised trial

Authors' conclusion

In this explorative study, a perioperative high-dose selenium-supplementation did not show beneficial effects on organ dysfunctions and mortality rates in patients with PCCS receiving tMCS.

Study context

Population
Cardiac surgery patients with post-cardiotomy cardiogenic shock (PCCS) treated with temporary mechanical circulatory support (tMCS)
Participants
39 patients
Comparison
High-dose selenium vs placebo
Primary endpoint
Duration of tMCS therapy
Methodological detailspost-hoc analysis, explorative, placebo-controlled
  • Post-hoc analysis
  • Explorative
  • Placebo-controlled

Primary result

As reported in the abstract

Duration of tMCS

P = 0.52

Secondary outcomes

Dialysis duration · longer in the selenium group

P = 0.048

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

The effect of high-dose selenium on mortality and postoperative organ dysfunction in post-cardiotomy cardiogenic shock patients supported with mechanical circulatory support – A post-hoc analysis of the SUSTAIN CSX trial. J Crit Care. Published 2 July 2024. doi:10.1016/j.jcrc.2024.154853

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.